{"DataElement":{"publicId":"2593051","version":"1","preferredName":"Melanoma Specimen Clark Level Value","preferredDefinition":"Definition of the Clark level or depth of involvement of a melanoma in the skin or a specimen.","longName":"MEL_LVL_SPEC_CLK_VAL","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2192160","version":"1","preferredName":"Melanoma Specimen Clark Level Involvement","preferredDefinition":"information related to the Clark level of involvement of a melanoma specimen.","longName":"MEL_SPEC_CLKLV_INVLT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206798","version":"1","preferredName":"Melanoma Specimen","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004:Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C3224:C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-04DC-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177473","version":"1","preferredName":"Involvement","preferredDefinition":"Involvement; a connection by participation or association or use.","longName":"Involvement","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5222-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8ED8E9A-0428-5285-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2593049","version":"1","preferredName":"Melanoma Level Value","preferredDefinition":"Definition of the depth of melanoma involvement in skin or a specimen.","longName":"MEL_LVL_VAL","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"23","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No source documentation","valueDescription":"No source documentation","ValueMeaning":{"publicId":"2590731","version":"1","preferredName":"No source documentation","longName":"2590731","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27F2D64C-2956-74FF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"285BE530-4485-41E0-E044-0003BA3F9857","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"REEVESD","dateModified":"2007-01-31","deletedIndicator":"No"},{"value":"I","valueDescription":"above basal lamina (in situ)","ValueMeaning":{"publicId":"2571757","version":"1","preferredName":"above basal lamina (in situ)","longName":"2571757","preferredDefinition":"A morphologic finding indicating that the cutaneous melanoma is confined to the epidermis and does not invade the dermis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clark Level I","conceptCode":"C94812","definition":"A morphologic finding indicating that the cutaneous melanoma is confined to the epidermis and does not invade the dermis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E55A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"LUY","dateModified":"2015-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"285BE530-4492-41E0-E044-0003BA3F9857","beginDate":"2004-08-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"REEVESD","dateModified":"2007-01-31","deletedIndicator":"No"},{"value":"II","valueDescription":"extension into papillary dermis","ValueMeaning":{"publicId":"2571758","version":"1","preferredName":"extension into papillary dermis","longName":"2571758","preferredDefinition":"A morphologic finding indicating that the cutaneous melanoma has invaded part of the papillary dermis but the malignant cellular infiltrate has not reached the papillary-reticular dermis interface.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clark Level II","conceptCode":"C94813","definition":"A morphologic finding indicating that the cutaneous melanoma has invaded part of the papillary dermis but the malignant cellular infiltrate has not reached the papillary-reticular dermis interface.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E55B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"LUY","dateModified":"2015-01-29","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"285BE530-449E-41E0-E044-0003BA3F9857","beginDate":"2004-08-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"REEVESD","dateModified":"2007-01-31","deletedIndicator":"No"},{"value":"III","valueDescription":"interface papillary-reticular dermis","ValueMeaning":{"publicId":"2571759","version":"1","preferredName":"interface papillary-reticular dermis","longName":"2571759","preferredDefinition":"A morphologic finding indicating that the cutaneous melanoma has invaded the entire thickness of the papillary dermis but the malignant cellular infiltrate does not extend into the reticular dermis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clark Level III","conceptCode":"C94814","definition":"A morphologic finding indicating that the cutaneous melanoma has invaded the entire thickness of the papillary dermis but the malignant cellular infiltrate does not extend into the reticular dermis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E55C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"LUY","dateModified":"2015-01-29","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"285BE530-44AA-41E0-E044-0003BA3F9857","beginDate":"2004-08-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"REEVESD","dateModified":"2007-01-31","deletedIndicator":"No"},{"value":"IV","valueDescription":"reticular dermis","ValueMeaning":{"publicId":"2571760","version":"1","preferredName":"reticular dermis","longName":"2571760","preferredDefinition":"A morphologic finding indicating that the cutaneous melanoma has invaded the reticular dermis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clark Level IV","conceptCode":"C94815","definition":"A morphologic finding indicating that the cutaneous melanoma has invaded the reticular dermis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E55D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"LUY","dateModified":"2015-01-29","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"285BE530-44B6-41E0-E044-0003BA3F9857","beginDate":"2004-08-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"REEVESD","dateModified":"2007-01-31","deletedIndicator":"No"},{"value":"V","valueDescription":"subcutaneous fat","ValueMeaning":{"publicId":"2571761","version":"1","preferredName":"subcutaneous fat","longName":"2571761","preferredDefinition":"A morphologic finding indicating that the cutaneous melanoma has invaded the subcutaneous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clark Level V","conceptCode":"C94816","definition":"A morphologic finding indicating that the cutaneous melanoma has invaded the subcutaneous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E55E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"LUY","dateModified":"2015-01-29","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"285BE530-44C2-41E0-E044-0003BA3F9857","beginDate":"2004-08-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"REEVESD","dateModified":"2007-01-31","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AE1E2A1-46C6-6C31-E040-BB89AD434C6B","beginDate":"2010-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-08","modifiedBy":"ONEDATA","dateModified":"2010-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2593048","version":"1","preferredName":"Melanoma Level Value","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004:A position on a scale measuring intensity, quality, or amount.  (NCI):A numerical quantity measured or assigned or computed.","longName":"C3224:C25554:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Level","conceptCode":"C25554","definition":"A position on a scale measuring intensity, quality, or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"285BE529-23B8-4109-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"ONEDATA","dateModified":"2007-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"285BE529-23C9-4109-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"KNABLEJ","dateModified":"2021-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812607","version":"1","longName":"Arizona New CDEs","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812205","version":"1","longName":"Arizona Cancer Center","context":"NCIP"},{"publicId":"2812575","version":"1","longName":"AZCC 0210","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"}]},{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7634324","version":"1","longName":"CM Baseline","context":"OCCPR"}]}],"AlternateNames":[{"name":"Melanoma Clark Level Value","type":"TCGA_Name","context":"NCIP"},{"name":"melanoma_clark_level_value","type":"TCGA_XML_Name","context":"NCIP"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"OCCPR","type":"USED_BY","context":"OCCPR"}],"ReferenceDocuments":[{"name":"Clark Level","type":"Preferred Question Text","description":"Clark Level","url":null,"context":"NCIP"},{"name":"TCGA Comment","type":"COMMENT","description":"at diagnosis","url":null,"context":"NCIP"},{"name":"Clark level of invasion","type":"Alternate Question Text","description":"Clark level of invasion","url":null,"context":"SWOG"},{"name":"CPTAC-CM-1","type":"Alternate Question Text","description":"Clark Level (use highest level if multiple)","url":null,"context":"OCCPR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"285D2B28-3184-4FC1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"SOKKERL","dateModified":"2021-04-23","changeDescription":"Curated to support Arizona Cancer Center adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}